ESG Report

The report presents Jazz Pharmaceuticals' inaugural ESG disclosures through 2021, organized around Patients, People, Community and Planet. It describes Board-level ESG oversight through the Nominating and Corporate Governance Committee, a workforce of 3,120 permanent employees, and social performance data on gender and leadership. Environmental disclosures cover facility-level energy, water and waste management, including renewable electricity at Athlone and resource-efficiency initiatives at Villa Guardia.